Mini Curriculum Vitae

Fabrice PIROT

PhotoPIROT
Equipe : Pôle Rockfeller
Courriel : fabrice.pirot@univ-lyon1.fr
Téléphone : +33(0)4-78-78-56-86
Statut : Professeur


2017
8.  Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles. 
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60  Icon PUBMED

7.  Comparison of four different fuller’s earth formulations in skin decontamination. 
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol  :  Icon PUBMED

2016
6.  Percutaneous absorption of benzophenone-3 loaded lipid nanoparticles and polymeric nanocapsules: A comparative study. 
Gilbert E, Roussel L, Serre C, Sandouk R, Salmon D, Kirilov P, Haftek M, Falson F, Pirot F
(2016) Int J Pharm 504 :48-58  Icon PUBMED

5.  Ex-Vivo percutaneous absorption of enrofloxacin: Comparison of LMOG organogel vs. pentravan cream. 
Kirilov P, Tran Vh, Ducrotte-tassel A, Salvi Jp, Perrot S, Haftek M, Boulieu R, Pirot F
(2016) Int J Pharm 498 :170-7  Icon PUBMED

2015
4.  Deleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic molecules. 
Abdayem R, Roussel L, Zaman N, Pirot F, Gilbert E, Haftek M
(2015) Exp Dermatol 24 :972-4  Icon PUBMED

3.  Measurement, analysis and prediction of topical UV filter bioavailability. 
Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach Hi, Pirot F
(2015) Int J Pharm 478 :804-10  Icon PUBMED

2.  New easy handling and sampling device for bioavailability screening of topical formulations. 
Salmon D, Gilbert E, Gioia B, Haftek M, Pivot C, Verrier B, Pirot F
(2015) Eur J Dermatol 25 Suppl 1 :23-9  Icon PUBMED

1.  [Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study]. 
Tall Ml, Lehmann S, Diouf E, Gerard C, Filali S, Gabelle A, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C
(2015) Ann Pharm Fr 73 :43-59  Icon PUBMED